Nuzenio

Racura

Racura news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Racura Oncology Ltd (FN3.F) Stock Price, News, Quote & History - Yahoo! Finance CanadaYahoo! Finance Canada · Sat, 08 Aug 2026 17:05:19 GMT Racura Oncology (ASX:RAC) in Focus as Investors Track Precision Medicine Progress - KalkineKalkine · Fri, 07 Aug 2026 02:52:00 GMT Racura Oncology (ASX:RAC): First Patient Dosed in HARNESS-1 Starts the Clinical Clock - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMT Patient treated in RACURA trial of RC220 in non‑small cell lung cancer - BiotechDispatchBiotechDispatch · Wed, 29 Jul 2026 07:00:00 GMT Racura Oncology CEO to Present Cancer Drug Pipeline at TechKnow Invest Conference on 29 July 2026 - KalkineKalkine · Wed, 29 Jul 2026 07:00:00 GMT Racura Oncology's RC220 Passes First Safety Review as HARNESS-1 Trial Advances with Caution - KalkineKalkine · Wed, 29 Jul 2026 07:00:00 GMT Racura Oncology CEO Dr Daniel Tillett to Showcase Cancer Drug Pipeline at TechKnow Invest Conference on 29 July 2026 - Kalkine MediaKalkine Media · Wed, 29 Jul 2026 07:00:00 GMT Racura Oncology's RC220 Clears Initial Safety Review in HARNESS-1 Trial Amid Careful Dose Escalation - Kalkine MediaKalkine Media · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Sat, 08 Aug 2026 17:05:19 GMTRacura Oncology Ltd (FN3.F) Stock Price, News, Quote & History - Yahoo! Finance Canada

Fri, 07 Aug 2026 02:52:00 GMTRacura Oncology (ASX:RAC) in Focus as Investors Track Precision Medicine Progress - Kalkine

Fri, 31 Jul 2026 07:00:00 GMTRacura Oncology (ASX:RAC): First Patient Dosed in HARNESS-1 Starts the Clinical Clock - Kalkine

Wed, 29 Jul 2026 07:00:00 GMTPatient treated in RACURA trial of RC220 in non‑small cell lung cancer - BiotechDispatch

Wed, 29 Jul 2026 07:00:00 GMTRacura Oncology CEO to Present Cancer Drug Pipeline at TechKnow Invest Conference on 29 July 2026 - Kalkine

Wed, 29 Jul 2026 07:00:00 GMTRacura Oncology's RC220 Passes First Safety Review as HARNESS-1 Trial Advances with Caution - Kalkine

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

HARNESS6 live mentions Kalkine Racura Oncology5 live mentions Racura Oncology4 live mentions ASX4 live mentions RAC4 live mentions Pipeline4 live mentions TechKnow Invest Conference4 live mentions July4 live mentions Review4 live mentions Stock Price2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Racura.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.